Related references
Note: Only part of the references are listed.A novel antisense oligonucleotide anchored on the intronic splicing enhancer of hTERT pre-mRNA inhibits telomerase activity and induces apoptosis in glioma cells
Fei Wang et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Telomeres and telomerase: three decades of progress
Jerry W. Shay et al.
NATURE REVIEWS GENETICS (2019)
NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells
Mohammed E. Sayed et al.
ONCOGENE (2019)
Sequence, Structure, and Context Preferences of Human RNA Binding Proteins
Daniel Dominguez et al.
MOLECULAR CELL (2018)
Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
Patricia Reyes-Uribe et al.
ONCOGENE (2018)
NOVA1 regulates hTERT splicing and cell growth in non-small cell lung cancer
Andrew T. Ludlow et al.
NATURE COMMUNICATIONS (2018)
RNA Polymerase II Phosphorylated on CTD Serine 5 Interacts with the Spliceosome during Co-transcriptional Splicing
Takayuki Nojima et al.
MOLECULAR CELL (2018)
The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer
Ettaib El Marabti et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2018)
Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer
Ricardo Leao et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
Alternative Splicing of hTERT Pre-mRNA: A Potential Strategy for the Regulation of Telomerase Activity
Xuewen Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Recent advances in RNA folding
Joerg Fallmann et al.
JOURNAL OF BIOTECHNOLOGY (2017)
Systematic analysis of telomere length and somatic alterations in 31 cancer types
Floris P. Barthel et al.
NATURE GENETICS (2017)
Mechanistic insights into precursor messenger RNA splicing by the spliceosome
Yigong Shi
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Telomerase reverse transcriptase expression protects transformed human cells against DNA-damaging agents, and increases tolerance to chromosomal instability
H. B. Fleisig et al.
ONCOGENE (2016)
Human telomerase reverse transcriptase regulation by DNA methylation, transcription factor binding and alternative splicing (Review)
Brittany A. Avin et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression
Ekta Khattar et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance
Jonathan H. Teichroeb et al.
RNA BIOLOGY (2016)
Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner
Robin E. Frink et al.
ONCOTARGET (2016)
Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies
Mohammad A. Jafri et al.
GENOME MEDICINE (2016)
Regulation of the Human Telomerase Gene TERT by Telomere Position Effect-Over Long Distances (TPE-OLD): Implications for Aging and Cancer
Wanil Kim et al.
PLOS BIOLOGY (2016)
NOVA2-mediated RNA regulation is required for axonal pathfinding during development
Yuhki Saito et al.
ELIFE (2016)
Quantitative assessment of telomerase components in cancer cell lines
Semih Can Akincilar et al.
FEBS LETTERS (2015)
Computational Prediction of RNA-Binding Proteins and Binding Sites
Jingna Si et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection
Elizabeth H. Blackburn et al.
SCIENCE (2015)
Perifosine as a potential novel anti-telomerase therapy
Brody Holohan et al.
ONCOTARGET (2015)
A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase
Anagha Killedar et al.
PLOS GENETICS (2015)
A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer
A. A. Chiappori et al.
ANNALS OF ONCOLOGY (2015)
Induction of Telomere Dysfunction Mediated by the Telomerase Substrate Precursor 6-Thio-2'-Deoxyguanosine
Ilgen Mender et al.
CANCER DISCOVERY (2015)
Inactive C-terminal telomerase reverse transcriptase insertion splicing variants are dominant-negative inhibitors of telomerase
Shusen Zhu et al.
BIOCHIMIE (2014)
Context-dependent control of alternative splicing by RNA-binding proteins
Xiang-Dong Fu et al.
NATURE REVIEWS GENETICS (2014)
Inventory of telomerase components in human cells reveals multiple subpopulations of hTR and hTERT
Linghe Xi et al.
NUCLEIC ACIDS RESEARCH (2014)
Quantitative telomerase enzyme activity determination using droplet digital PCR with single cell resolution
Andrew T. Ludlow et al.
NUCLEIC ACIDS RESEARCH (2014)
Hallmarks of alternative splicing in cancer
S. Oltean et al.
ONCOGENE (2014)
Telomerase Inhibitor Imetelstat (GRN163L) Limits the Lifespan of Human Pancreatic Cancer Cells
Katrina M. Burchett et al.
PLOS ONE (2014)
Alternative splicing regulation of telomerase: a new paradigm?
Mandy S. Wong et al.
TRENDS IN GENETICS (2014)
Regulation of human telomerase splicing by RNA:RNA pairing
Mandy S. Wong et al.
NATURE COMMUNICATIONS (2014)
The Major Reverse Transcriptase-Incompetent Splice Variant of the Human Telomerase Protein Inhibits Telomerase Activity but Protects from Apoptosis
Imke Listerman et al.
CANCER RESEARCH (2013)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen et al.
NATURE GENETICS (2013)
Regulation of Telomerase Alternative Splicing: A Target for Chemotherapy
Mandy S. Wong et al.
CELL REPORTS (2013)
Alternatively Spliced Telomerase Reverse Transcriptase Variants Lacking Telomerase Activity Stimulate Cell Proliferation
Radmila Hrdlickova et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Is telomerase a viable target in cancer?
C. M. Buseman et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2012)
Exclusion of Exon 2 Is a Common mRNA Splice Variant of Primate Telomerase Reverse Transcriptases
Johanna B. Withers et al.
PLOS ONE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth
Calin O. Marian et al.
CLINICAL CANCER RESEARCH (2010)
Biases in Illumina transcriptome sequencing caused by random hexamer priming
Kasper D. Hansen et al.
NUCLEIC ACIDS RESEARCH (2010)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
Splicing regulation: From a parts list of regulatory elements to an integrated splicing code
Zefeng Wang et al.
RNA (2008)
The relationship between non-protein-coding DNA and eukaryotic complexity
Ryan J. Taft et al.
BIOESSAYS (2007)
Nova autoregulation reveals dual functions in neuronal splicing
BK Dredge et al.
EMBO JOURNAL (2005)
Does a sentinel or a subset of short telomeres determine replicative senescence?
Y Zou et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
An unappreciated role for RNA surveillance
RT Hillman et al.
GENOME BIOLOGY (2004)
Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells
XM Yi et al.
NUCLEIC ACIDS RESEARCH (2001)
Protein diversity from alternative splicing: A challenge for bioinformatics and post-genome biology
DL Black
CELL (2000)
Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability
KB Jensen et al.
NEURON (2000)
An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity
XM Yi et al.
NEOPLASIA (2000)
Share Paper
